Why did Tesla face a new self-driving probe?
How will the US government shutdown impact markets?
What caused Nvidia stock to surge recently?
Why is China tightening rare earth export controls?
How did Israel-Hamas ceasefire affect oil prices?
What’s behind Goldman Sachs’ strategic confidence?
Why is JPMorgan requiring biometric data for staff?
Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $4.7 Billion Buyout
investors.com/news/technology/novo-nordisk-akero-therapeutics-acquisition-mash-treatment
Novo Nordisk said Thursday it will pay $4.7 billion up front to acquire Akero Therapeutics for its experimental liver disease treatment.
The post Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $4.7 Billion Buyout appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-10-09 12:55:08.